Accueil » Communiqués de presse » Valbiotis is patented for its active substance TOTUM•63 in China, a large potential market for the prevention of type 2 diabetes and metabolic diseases (IN FRENCH).
Les communiqués de presse
19May2021
Valbiotis is patented for its active substance TOTUM•63 in China, a large potential market for the prevention of type 2 diabetes and metabolic diseases (IN FRENCH).
We use cookies to guarantee the best experience on our site, to make statistics, to offer you third party services such as video like Youtube, social networks sharing. By clicking on validate and closing this banner, you accept the deposit of cookies.AcceptRefuseMore information
You can revoke your consent at any time by using the "Revoke Consent" button.Revoke consent
